We are live on
!
Find out more
SGC
Slocum, Gordon & Co Portfolio holdings
AUM
$151M
1-Year Est. Return
26.83%
This Fund
S&P 500
This Quarter
Est. Return
+14.74%
1 Year Est. Return
+26.83%
3 Year Est. Return
+55.15%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$155M
AUM Growth
–
Cap. Flow
+$150M
Cap. Flow
% of AUM
96.4%
Top 10 Holdings %
Top 10 Hldgs %
62.1%
Holding
142
New
142
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$13.3M |
| 2 |
Johnson & Johnson
JNJ
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$10.2M |
| 4 |
Pfizer
PFE
|
+$9.87M |
| 5 |
American Electric Power
AEP
|
+$8.88M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.13% |
| 2 | Utilities | 25.16% |
| 3 | Consumer Staples | 12.8% |
| 4 | Energy | 10.84% |
| 5 | Communication Services | 5.52% |
Similar funds
CAM
FC
JIM
WBCM
BDS
CCM
SHF
RB
Slocum, Gordon & Co's Q4 2022 Portfolio in Review
Q4 2022 is the first quarter with a 13F filing on record for Slocum, Gordon & Co, which disclosed 142 positions worth $155M. Its ten largest holdings account for 62% of the portfolio.
Its largest position is Merck: 130,543 shares worth $14.5M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, followed by Utilities and Consumer Staples.
- Slocum, Gordon & Co's largest Q4 2022 buy was Merck: 130,543 shares worth $14.5M.
- Slocum, Gordon & Co's ten largest holdings make up 62% of its $155M portfolio in Q4 2022.
- Slocum, Gordon & Co disclosed 142 positions in Q4 2022, its first 13F filing on record.
Based on Slocum, Gordon & Co's 13F filing for Q4 2022, filed 6 Dec 2023.